Randomized Controlled Feasibility Trial of Robot-assisted Versus Conventional Open Partial Nephrectomy: The ROBOCOP II Study

被引:11
|
作者
Kowalewski, Karl -Friedrich [1 ]
Neuberger, Manuel [1 ]
Abate, Marie Angela Sidoti [1 ]
Kirchner, Marietta [2 ]
Haney, Caelan Max [3 ]
Siegel, Fabian [1 ]
Westhoff, Niklas [1 ]
Michel, Maurice-Stephan [1 ]
Honeck, Patrick [1 ]
Nuhn, Philipp [1 ]
Kriegmair, Maximilian Christian [1 ]
机构
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Urol & Urol Surg, Mannheim, Germany
[2] Heidelberg Univ, Inst Med Biometry, Heidelberg, Germany
[3] Univ Leipzig, Dept Urol, Leipzig, Germany
来源
EUROPEAN UROLOGY ONCOLOGY | 2024年 / 7卷 / 01期
关键词
Kidney cancer; Randomized controlled trial; Robotic surgery; Evidence-based medicine; Partial nephrectomy; ISCHEMIA;
D O I
10.1016/j.euo.2023.05.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There is no evidence from randomized controlled trials (RCTs) comparing robot -assisted partial nephrectomy (RAPN) and open partial nephrectomy (OPN). Objective: To assess the feasibility of trial recruitment and to compare surgical outcomes between RAPN and OPN. Design, setting, and participants: ROBOCOP II was designed as single -center, open -label, feasibility RCT. Patients with suspected localized renal cell carcinoma referred for PN were randomized at a 1:1 ratio to either RAPN or OPN. Outcome measurements and statistical analysis: The primary outcome was the feasibility of recruitment, assessed as the accrual rate. Secondary outcomes included perioperative and postoperative data. Data were analyzed descriptively in a modified intentionto -treat population consisting of randomized patients who underwent surgery. Results and limitations: A total of 50 patients underwent RAPN or OPN (accrual rate 65%). In comparison to OPN, RAPN had lower blood loss (OPN 361 ml, standard deviation [SD] 238; RAPN 149 ml, SD 122; difference 212 ml, 95% confidence interval [CI] 105- 320; p < 0.001), less need for opioids (OPN 46%; RAPN 16%; difference 30%, 95% CI 5- 54; p = 0.024), and fewer complications according to the mean Comprehensive Complication Index (OPN 14, SD 16; RAPN 5, SD 15; difference 9, 95% CI 0-18; p = 0.008). OPN has a shorter operative time (OPN 112 min, SD 29; RAPN 130 min, SD 32; difference -18 min, 95% CI -35 to -1; p = 0.046) and warm ischemia time (OPN 8.7 min, SD 7.1; RAPN 15.4 min, SD 7.0; difference 6.7 min, 95% CI -10.7 to -2.7; p = 0.001). There were no differences between RAPN and OPN regarding postoperative kidney function. Conclusions: This first RCT comparing OPN and RAPN met the primary outcome of the feasibility of recruitment; however, the window for future RCTs is closing. Each approach has advantages over the other, and both remain safe and effective options. Patient summary: For patients with a kidney tumor, open surgery and robot -assisted keyhole surgery are both feasible and safe approaches for partial removal of the affected kidney. Each approach has known advantages. Long -term follow-up will explore differences in quality of life and cancer control outcomes. (c) 2023 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [1] ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocol
    Kowalewski, Karl-Friedrich
    Abate, Marie Angela Sidoti
    Neuberger, Manuel
    Kirchner, Marietta
    Krisam, Regina
    Egen, Luisa
    Haney, Caelan Max
    Siegel, Fabian
    Michel, Maurice-Stephan
    Honeck, Patrick
    Nuhn, Philipp
    Westhoff, Niklas
    Kriegmair, Maximilian Christian
    BMJ OPEN, 2021, 11 (11):
  • [2] Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial
    Wei, Mengchao
    Yang, Wenjie
    Zhou, Jingmin
    Ye, Zixing
    Ji, Zhigang
    Dong, Jie
    Xu, Weifeng
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [3] Quality-of-life outcomes of the ROBOtic-assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial
    Sidoti Abate, Marie Angela
    Menold, Hanna Saskia
    Neuberger, Manuel
    Kirchner, Marietta
    Haney, Caelan Max
    Nuhn, Philipp
    Westhoff, Niklas
    Honeck, Patrick
    Michel, Maurice-Stephan
    Kriegmair, Maximilian Christian
    Kowalewski, Karl-Friedrich
    BJU INTERNATIONAL, 2024, 134 (03) : 434 - 441
  • [4] Open versus robot-assisted partial nephrectomy in a solitary kidney
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2023, 54 (05) : 344 - 344
  • [5] Quality of life outcomes after robotic-assisted versus open partial nephrectomy: Results from the randomized ROBOCOP II trial
    Kowalewski, K-F.
    Sidoti, Abate M. A.
    Menold, H. S.
    Neuberger, M.
    Kirchner, M.
    Haney, C. M.
    Westhoff, N.
    Michel, M. S.
    Honeck, P.
    Nuhn, P.
    Kriegmair, M. C.
    EUROPEAN UROLOGY, 2023, 83
  • [6] Partial nephrectomy for small children: Robot-assisted versus open surgery
    Ballouhey, Quentin
    Binet, Aurelien
    Clermidi, Pauline
    Braik, Karim
    Villemagne, Thierry
    Cros, Jerome
    Lardy, Hubert
    Fourcade, Laurent
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (12) : 855 - 860
  • [7] Open Versus Robot-Assisted Partial Nephrectomy: Effect on Clinical Outcome
    Lee, Sangchul
    Oh, Jongjin
    Hong, Seong Kyu
    Lee, Sang Eun
    Byun, Seok-Soo
    JOURNAL OF ENDOUROLOGY, 2011, 25 (07) : 1181 - 1185
  • [8] Commentary on open versus robot-assisted partial nephrectomy in a solitary kidney
    Graser, Annabel
    AKTUELLE UROLOGIE, 2023, 54 (05) : 345 - 345
  • [9] Partial nephrectomy for hilar tumors: comparison of conventional open and robot-assisted approaches
    Miyake, Hideaki
    Hinata, Nobuyuki
    Imai, Satoshi
    Furukawa, Junya
    Tanaka, Kazushi
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 808 - 813
  • [10] Partial nephrectomy for hilar tumors: comparison of conventional open and robot-assisted approaches
    Hideaki Miyake
    Nobuyuki Hinata
    Satoshi Imai
    Junya Furukawa
    Kazushi Tanaka
    Masato Fujisawa
    International Journal of Clinical Oncology, 2015, 20 : 808 - 813